Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
News
2014
Progress on access to medicines at WHA67, but WHO funding sorely needed
World Health Assembly: HAI and ARC intervention on antimicrobial resistance, including antibiotic resistance
World Health Assembly 67: HAI and KEI intervention on the Consultative Expert Working Group on Research and Development
World Health Assembly 67: HAI intervention on access to essential medicines
World Health Assembly 67: HAI intervention on the WHO's framework of engagement with non-state actors
Action on antimicrobial resistance: It’s about time (and we’re running out)
Tamiflu review shows desperate need for full clinical trials data transparency
Governments must ensure Big Pharma’s expansion in Africa doesn’t impede generics supply
New materials help assess medicines policies and interventions
A new (and improved) model to regulate pharmaceutical promotion
Enhancing accountability in the medicines market: The Medicines Transparency Alliance
Bayer CEO's callous comments highlight failure of current biomedical innovation model
Leaks and Lies: Pharma’s strategy to derail South Africa’s intellectual property reforms exposed
Selected R&D demonstration projects disappointing: Innovation models with new incentive mechanisms needed
Regulation critical to clinical trials data transparency in Europe
2013
When politicians go to the movies
True clinical trials transparency? Not quite, EFPIA.
Conference contemplations: ‘Pharmaceuticals and global health – inequalities and innovation in the 21st century’
Good week for access to affordable medicines
Despite concrete steps forward, the ENVI vote on clinical trials regulation falls short on transparency
Bracing for another delay – open innovation at the WHO?
2011